Cohen & Malad, LLP managing partner, Irwin B. Levin, has been appointed to serve on the Plaintiffs’ Steering Committee for GranuFlo and NaturaLyte claims consolidated in Massachusetts State Court. Hundreds of lawsuits filed against Fresenius Medical Care, the maker of GranuFlo and NaturaLyte dialysis products, have been combined before Middlesex County Superior Court Judge Maynard M. Kirpalani.
As a member of the Plaintiffs’ Steering Committee, Levin will be responsible for assisting in the pretrial activities and prosecution of these claims. Mr. Levin has held many leadership roles over his 35 years of litigation practice including a position on the executive committee for the class action against Swiss banks on behalf of Holocaust survivors. He played a significant part in lengthy negotiations that culminated in the $1.25 billion settlement presented to the court in that action.
GranuFlo and NaturaLyte are two products used in kidney dialysis treatment. The use of these products has been associated with low blood pressure and increased potassium build up in the body. An internal memo published by Fresenius Medical Care, the maker of these products and operator of dialysis clinics, noted that patients using these products face a six to eight times increased risk for suffering a heart attack or sudden cardiac death within 48 hours of treatment. The FDA learned of the memo and issued a Class I recall of all GranuFlo and NaturaLyte products. If you or someone you care about has undergone kidney dialysis treatment with GranuFlo or NaturaLyte and suffered a heart attack or serious cardiac event, contact us. Our product liability attorneys can provide you with a free case evaluation and discuss your legal rights and options.